Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters

Main subject
Language
Document Type
Year range
1.
IEEE Transactions on Automation Science & Engineering ; 19(2):646-662, 2022.
Article in English | Academic Search Complete | ID: covidwho-1788781

ABSTRACT

The ongoing coronavirus disease 2019 (COVID-19) is a pandemic causing millions of deaths, devastating social and economic disruptions. Testing individuals for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen of COVID-19, is critical for mitigating and containing COVID-19. Many countries are implementing group testing strategies against COVID-19 to improve testing capacity and efficiency while saving required workloads and consumables. A group of individuals’ nasopharyngeal/oropharyngeal (NP/OP) swab samples is mixed to conduct one test. However, existing group testing methods neglect the fact that mixing samples usually leads to substantial dilution of viral ribonucleic acid (RNA) of SARS-CoV-2, which seriously impacts the sensitivity of tests. In this paper, we aim to screen individuals infected with COVID-19 with as few tests as possible, under the premise that the sensitivity of tests is high enough. To achieve this goal, we propose an Adaptive Group Testing (AdaGT) method. By collecting information on the number of positive and negative samples that have been identified during the screening process, the AdaGT method can estimate the ratio of positive samples in real-time. Based on this ratio, the AdaGT algorithm adjusts its testing strategy adaptively between an individual testing strategy and a group testing strategy. The group size of the group testing strategy is carefully selected to guarantee that the sensitivity of each test is higher than a predetermined threshold and that this group contains at most one positive sample on average. Theoretical performance analysis on the AdaGT algorithm is provided and then validated in experiments. Experimental results also show that the AdaGT algorithm outperforms existing methods in terms of efficiency and sensitivity. Note to Practitioners—Real-time reverse transcription-polymerase chain reaction (rRT-PCR) tests provide scope for automation and are one of the most widely used laboratory methods for detecting the SARS-CoV-2 virus. This paper is motivated by the following challenges: (1) Many countries are experiencing an acute shortage of professionals and consumables for conducting rRT-PCR tests;(2) Group sizes of existing group testing methods against COVID-19 may not be optimal, which adversely impacts the efficiency of the screening of the SARS-CoV-2 virus;(3) Existing group testing methods do not consider the fact that the sensitivity of rRT-PCR tests usually decreases with the group size. The objective of this paper is to improve the efficiency and sensitivity of large-scale screening against COVID-19. For achieving this goal, we propose an Adaptive Group Testing (AdaGT) algorithm, which has the following advantages: (1) It can improve the efficiency for screening the SARS-CoV-2 virus, mainly by adaptively adjusting its testing strategy between an individual testing strategy and a group testing strategy based upon an estimated ratio of positive samples during the screening process;(2) It can guarantee a high sensitivity of the rRT-PCR tests by determining the group sizes of the group testing strategy based upon some constraints;(3) We derive an appropriate threshold for the estimated ratio of positive samples such that the AdaGT algorithm can achieve a minimum average number of rRT-PCR tests and can be directly employed in practical applications. [ FROM AUTHOR] Copyright of IEEE Transactions on Automation Science & Engineering is the property of IEEE and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)

2.
IEEE J Biomed Health Inform ; 26(2): 482-493, 2022 02.
Article in English | MEDLINE | ID: covidwho-1570201

ABSTRACT

The pathogen of the ongoing coronavirus disease 2019 (COVID-19) pandemic is a newly discovered virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Testing individuals for SARS-CoV-2 plays a critical role in containing COVID-19. For saving medical personnel and consumables, many countries are implementing group testing against SARS-CoV-2. However, existing group testing methods have the following limitations: (1) The group size is determined without theoretical analysis, and hence is usually not optimal. This adversely impacts the screening efficiency. (2) These methods neglect the fact that mixing samples together usually leads to substantial dilution of the SARS-CoV-2 virus, which seriously impacts the sensitivity of tests. In this paper, we aim to screen individuals infected with COVID-19 with as few tests as possible, under the premise that the sensitivity of tests is high enough. We propose an eXpectation Maximization based Adaptive Group Testing (XMAGT) method. The basic idea is to adaptively adjust its testing strategy between a group testing strategy and an individual testing strategy such that the expected number of samples identified by a single test is larger. During the screening process, the XMAGT method can estimate the ratio of positive samples. With this ratio, the XMAGT method can determine a group size under which the group testing strategy can achieve a maximal expected number of negative samples and the sensitivity of tests is higher than a user-specified threshold. Experimental results show that the XMAGT method outperforms existing methods in terms of both efficiency and sensitivity.


Subject(s)
COVID-19 , Health Personnel , Humans , Motivation , Pandemics , SARS-CoV-2
3.
Security and Communication Networks ; 2021, 2021.
Article in English | ProQuest Central | ID: covidwho-1268144

ABSTRACT

Contact tracing is a critical tool in containing epidemics such as COVID-19. Researchers have carried out a lot of work on contact tracing. However, almost all of the existing works assume that their clients and authorities have large storage space and powerful computation capability and clients can implement contact tracing on their own mobile devices such as mobile phones, tablet computers, and wearable computers. With the widespread outbreaks of the epidemics, these approaches are of less robustness to a larger scale of datasets when it comes to resource-constrained clients. To address this limitation, we propose a publicly verifiable contact tracing algorithm in cloud computing (PvCT), which utilizes cloud services to provide storage and computation capability in contact tracing. To guarantee the integrity and accuracy of contact tracing results, PvCT applies a novel set accumulator-based authentication data structure whose computation is outsourced, and the client can check whether returned results are valid. Furthermore, we provide rigorous security proof of our algorithm based on the q-Strong Bilinear Diffie–Hellman assumption. Detailed experimental evaluation is also conducted on three real-world datasets. The results show that our algorithm is feasible within milliseconds of client CPU time and can significantly reduce the storage overhead from the size of datasets to a constant 128 bytes.

SELECTION OF CITATIONS
SEARCH DETAIL